{
  "id": [
    "32803479"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32803479"
  ],
  "pmcid": [
    "PMC7427755"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7427755"
      ]
    }
  ],
  "doi": [
    "10.1007/s10787-020-00744-0"
  ],
  "title": [
    "COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties."
  ],
  "authorString": [
    "Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Asif M"
          ],
          "firstName": [
            "Muhammad"
          ],
          "lastName": [
            "Asif"
          ],
          "initials": [
            "M"
          ],
          "authorId": [
            {
              "_": "0000-0001-8989-9945",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan. asif_pharmacist45@yahoo.com."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Saleem M"
          ],
          "firstName": [
            "Mohammad"
          ],
          "lastName": [
            "Saleem"
          ],
          "initials": [
            "M"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Saadullah M"
          ],
          "firstName": [
            "Malik"
          ],
          "lastName": [
            "Saadullah"
          ],
          "initials": [
            "M"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Yaseen HS"
          ],
          "firstName": [
            "Hafiza Sidra"
          ],
          "lastName": [
            "Yaseen"
          ],
          "initials": [
            "HS"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Al Zarzour R"
          ],
          "firstName": [
            "Raghdaa"
          ],
          "lastName": [
            "Al Zarzour"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Penang, Malaysia."
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-8989-9945",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "5"
      ],
      "volume": [
        "28"
      ],
      "journalIssueId": [
        "3032885"
      ],
      "dateOfPublication": [
        "2020 Oct"
      ],
      "monthOfPublication": [
        "10"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-10-01"
      ],
      "journal": [
        {
          "title": [
            "Inflammopharmacology"
          ],
          "ISOAbbreviation": [
            "Inflammopharmacology"
          ],
          "medlineAbbreviation": [
            "Inflammopharmacology"
          ],
          "NLMid": [
            "9112626"
          ],
          "ISSN": [
            "0925-4692"
          ],
          "ESSN": [
            "1568-5608"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "1153-1161"
  ],
  "abstractText": [
    "Coronavirus disease of 2019 (COVID-19) has emerged as a global health threat. Unfortunately, there are very limited approved drugs available with established efficacy against the SARs-CoV-2 virus and its inflammatory complications. Vaccine development is actively being researched, but it may take over a year to become available to general public. Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19. Essential oils (EOs) have long been known to have anti-inflammatory, immunomodulatory, bronchodilatory, and antiviral properties and are being proposed to have activity against SARC-CoV-2 virus. Owing to their lipophilic nature, EOs are advocated to penetrate viral membranes easily leading to membrane disruption. Moreover, EOs contain multiple active phytochemicals that can act synergistically on multiple stages of viral replication and also induce positive effects on host respiratory system including bronchodilation and mucus lysis. At present, only computer-aided docking and few in vitro studies are available which show anti-SARC-CoV-2 activities of EOs. In this review, role of EOs in the prevention and treatment of COVID-19 is discussed. A discussion on possible side effects associated with EOs as well as anti-corona virus claims made by EOs manufacturers are also highlighted. Based on the current knowledge a chemo-herbal (EOs) combination of the drugs could be a more feasible and effective approach to combat this viral pandemic."
  ],
  "affiliation": [
    "Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan. asif_pharmacist45@yahoo.com."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Plants, Medicinal"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CH"
                  ],
                  "qualifierName": [
                    "chemistry"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Oils, Volatile"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Anti-Inflammatory Agents, Non-Steroidal"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunologic Factors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antiviral Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "COVID-19"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Essential oils",
        "Immunomodulatory",
        "Docking Studies",
        "Sarc-cov-2"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antiviral Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Anti-Inflammatory Agents, Non-Steroidal"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Oils, Volatile"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Immunologic Factors"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s10787-020-00744-0"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7427755"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7427755?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "33609198"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "Inflammopharmacology. 2021 Feb 20;:"
          ],
          "type": [
            "Erratum in"
          ],
          "orderIn": [
            "1"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "12"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-10-08"
  ],
  "dateOfCreation": [
    "2020-08-18"
  ],
  "firstIndexDate": [
    "2020-08-18"
  ],
  "fullTextReceivedDate": [
    "2020-08-20"
  ],
  "dateOfRevision": [
    "2021-02-20"
  ],
  "electronicPublicationDate": [
    "2020-08-14"
  ],
  "firstPublicationDate": [
    "2020-08-14"
  ]
}